Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or with Two Other Vaccines in Healthy Adolescents

Trial Identifier: MEQ00071
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: March 2021
Primary Completion Date: May 2022
Study Completion Date: May 2022
Condition: Healthy Volunteers; Meningococcal Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Hungary BUDAPEST, Hungary, 1042
Hungary Győr, Hungary, 9024
Hungary MISKOLC, Hungary, 3527
Hungary Szigetvár, Hungary, 7900
Hungary Szombathely, Hungary, 7900
Italy, Calabria Catanzaro, Calabria, Italy, 88100
Italy, Lombardia Milano, Lombardia, Italy, 20154
Italy, Not Known GENOVA, Not Known, Italy, IT-16132
Italy, Puglia Foggia, Puglia, Italy, 71122
Italy, Sicilia Palermo, Sicilia, Italy, 90131
Singapore Singapore, Singapore, 229899
Spain, Andalucia SEVILLA, Andalucia, Spain, 41013
Spain, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], Spain, 08035
Spain, Castilla y León Esplugues de Llobregat, Castilla y León, Spain, 08950
Spain, Galicia [Galicia] Santiago de Compostela, Galicia [Galicia], Spain, 15706
Spain, Madrid, Comunidad de Madrid, Madrid, Comunidad de, Spain, 28007
Spain, Valenciana, Comunidad Burriana, Valenciana, Comunidad, Spain, 12530
Spain, Valenciana, Comunidad Puzol, Valenciana, Comunidad, Spain, 46530
Spain, Valenciana, Comunidad Valencia, Valenciana, Comunidad, Spain, 46022
Spain, Valenciana, Comunidad Valencia, Valenciana, Comunidad, Spain, 46024
Spain, Valenciana, Comunidad Valencia, Valenciana, Comunidad, Spain, 46020
Spain, Valenciana, Comunidad Valencia, Valenciana, Comunidad, Spain, 46011